Results 111 to 120 of about 548,322 (291)

Impact of Artificial Intelligence on the Future of Clinical Pharmacy and Hospital Settings

Journal of Research in Pharmacy Practice
This review aimed to comprehensively evaluate the impact of artificial intelligence (AI) on the future of clinical pharmacy practice and hospital settings.
Hadi Hamishehkar, Mehrdad Shahidi
doaj   +1 more source

Addressing the Quality and Safety Gap Part I: Case Studies in Transforming Hospital Nursing and Building Cultures of Safety [PDF]

, 2009
Presents case studies of strategies four healthcare systems and a state government are using to address underlying causes in flawed systems: strengthening care processes, optimizing staffing, and promoting safe work habits.

core  

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

Molecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern, Kristian Holm, Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Corinna Bang, Bjørn Naume, Johannes R. Hov, Jon Amund Kyte   +7 more
wiley   +1 more source

Introducing Unit Dose Dispensing in a University Hospital – Effects on Medication Safety and Dispensing Time

Risk Management and Healthcare Policy
Hanne Katriina Ahtiainen,1,2 Carita Lindén-Lahti,1,2 Susanna Heininen,1 Anna-Riia Holmström,1 Lotta Schepel2,3 1Faculty of Pharmacy, University of Helsinki, Helsinki, Finland; 2HUS Pharmacy, Helsinki University Hospital, Helsinki, Finland; 3Quality and ...
Ahtiainen HK, Lindén-Lahti C, Heininen S, Holmström AR, Schepel L   +4 more
doaj  

Life, Life Support, and Death Principles, Guidelines, Policies and Procedures for Making Decisions That Respect Life [PDF]

, 1997
The following is the third edition of a booklet by the American Life League, Inc. The section on Ordinary/Extraordinary Means has been revised.
Byrne, Paul A., Colliton, William F., Evers, Joseph C., Fangman, Timothy R., Kramper, Ralph J., L\u27Ecuyer, Jerome, Nilges, Richard G., Sadick, Mary H., Shen, Jerome T.Y., Simon, Frank G.   +9 more
core   +1 more source

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

Molecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici, Soheil Akbari, Ceyda Caliskan, Canan Celiker, Ozden Oz, Leman Binokay, Gökhan Karakulah, Serif Senturk, Esra Erdal   +8 more
wiley   +1 more source

TECHNOLOGIES INVOLVED IN THE PROMOTION OF PATIENT SAFETY IN THE MEDICATION PROCESS: AN INTEGRATIVE REVIEW

Cogitare Enfermagem, 2017
This study sought to identify technologies existing in the literature and their use in promoting patient safety in the medication process.
Jéssika Wanessa Soares Costa, Jéssica Martinelli Martins de Assis, Marjorie Dantas Medeiros Melo, Suênia Silva de Mesquita Xavier, Gabriela de Sousa Martins Melo, Isabelle Katherinne Fernandes Costa   +5 more
doaj   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Wild medicine - exploring medication management challenges in transition and interaction across actors and health sectors related to older adults receiving polypharmacy: a qualitative study

BMC Geriatrics
Background Adverse drug events represent the largest category of incidents health professionals report to regional authorities in Denmark and remain a significant challenge globally.
Gitte Wind, Karen-Marie Olesen, Janne Friis Andersen, Line Hillersdal   +3 more
doaj   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source